aTYR PHARMA (ATYR) Amortization of Deferred Charges (2019 - 2021)
aTYR PHARMA's (ATYR) quarterly Amortization of Deferred Charges came in at $212000.0 in Q4 2021, up 79.66% on a YoY basis from $118000.0 in Q4 2020, and up 2.91% quarter-over-quarter from $206000.0 in Q3 2021.
Powered by 
Analysis
aTYR PHARMA (ATYR) Amortization of Deferred Charges (2019 - 2021) Analysis & Trends
aTYR PHARMA (ATYR) has reported Amortization of Deferred Charges for 3 consecutive years, with $212000.0 the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Amortization of Deferred Charges rose 79.66% year-over-year to $212000.0; the trailing twelve-month figure through Dec 2021 stood at $829000.0 (up 18.94% YoY), and the FY2021 full-year result was $829000.0, up 18.94% from the prior year.
- Amortization of Deferred Charges rose to $212000.0 in Q4 2021 per ATYR's latest filing, from $206000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $235000.0 in Q2 2021 and bottomed at $118000.0 in Q4 2020.
- Historically, Amortization of Deferred Charges has averaged $188083.3 across 3 years, with a median of $191000.0 in 2019.
- The sharpest annual moves came in 2020 and 2021: Amortization of Deferred Charges sank 39.49% in 2020, then surged 79.66% in 2021.
- Over 3 years, Amortization of Deferred Charges stood at $195000.0 in 2019, then tumbled by 39.49% to $118000.0 in 2020, then soared by 79.66% to $212000.0 in 2021.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $212000.0, $206000.0, and $235000.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 212,000.00 |
| Sep 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 235,000.00 |
| Mar 31, 2021 | 176,000.00 |
| Dec 31, 2020 | 118,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 206,000.00 |
| Mar 31, 2020 | 201,000.00 |
| Dec 31, 2019 | 195,000.00 |
| Sep 30, 2019 | 187,000.00 |
| Jun 30, 2019 | 180,000.00 |
| Mar 31, 2019 | 169,000.00 |